BUSINESS3 years ago
Generex Biotechnology Corp’s (OTCMKTS: GNBT) Subsidiary NuGenerex Immuno-Oncology valued at $535 million
Generex Biotechnology Corp’s (OTCMKTS: GNBT) subsidiary NuGenerex Immuno-Oncology has announced that the comp0any received a valuation of $535 million for a globally recognized, independent appraisal and...